<DOC>
	<DOCNO>NCT01861795</DOCNO>
	<brief_summary>The purpose observational study collect data vital sign , oxygen requirement data related ventilator care preterm neonates standard care treatment .</brief_summary>
	<brief_title>Observational Study Preterm Neonates Who Are Sufficiently Stable Non-Invasive Ventilatory Support</brief_title>
	<detailed_description>The objective study collect data vital sign , oxygen requirement data preterm infant breathe stably non-invasive ventilatory support . The data obtain study use compare data obtain future study add new medicinal product combination non-invasive ventilatory support accelerate lung development preterm infant . The study enroll approximately 40 patient . Participants receive investigational medicinal product device study . All participant vital sign , oxygen requirement data collect continuously throughout study . This multi-centre trial conduct Germany . The overall time participate study 10 week . Participants observe reach 36 week gestational age discharge hospital .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<criteria>1 . Written , inform consent parent legal guardian ( ) obtain ( admission , prior delivery ) . 2 . Preterm neonate bear 27+0 gestational week ( GW ) sufficiently stable nasal continuous positive airway pressure ( CPAP ) . Upper limit 36+0 GW . 3 . Participants ' minimum weight birth must 800 g. Upper weight limit 2500 g. 4 . CPAPpositive endexpiratory pressure ( PEEP ) must ≥5 cm ≤ 8 cm H2O . 5 . Fraction oxygen ( O2 ) ventilator outlet gas flow ( FiO2 ) ≥ 30 % reach saturation goal ( SpO2 88 % 96 % ) time period B0 T0 . 1 . FiO2 &gt; 50 % reach saturation goal ( saturation peripheral oxygen ( SpO2 ) 88 % 96 % ) time period 30 minute birth ( B0 ) 45 minute birth ( T0 ) . 2 . Presence severe respiratory distress syndrome ( RDS ) necessitate immediate intubation surfactant rescue entry study , necessitate surfactant rescue prior entry study . 3 . Known lifethreatening congenital anomaly genetic syndrome . 4 . Participation interventional study parallel observational study .</criteria>
	<gender>All</gender>
	<minimum_age>27 Weeks</minimum_age>
	<maximum_age>36 Weeks</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>